78 related articles for article (PubMed ID: 2549225)
21. [Evaluation on blood clearance and hepatic uptake of 99mTc-GSA in rats with blood flow conversion].
Ohno K
Hokkaido Igaku Zasshi; 1997 May; 72(3):297-307. PubMed ID: 9226469
[TBL] [Abstract][Full Text] [Related]
22. Local identifiability of a receptor-binding radiopharmacokinetic system having measured parameters of known uncertainty.
Vera DR; Scheibe PO; Banin Y; Stadalnik RC
IEEE Trans Biomed Eng; 1994 Sep; 41(9):891-7. PubMed ID: 7959816
[TBL] [Abstract][Full Text] [Related]
23. Comparison of two compartmental models for describing receptor ligand kinetics and receptor availability in multiple injection PET studies.
Morris ED; Alpert NM; Fischman AJ
J Cereb Blood Flow Metab; 1996 Sep; 16(5):841-53. PubMed ID: 8784229
[TBL] [Abstract][Full Text] [Related]
24. [Characterization of receptor-mediated binding of 99mTc-NGA in vitro].
Guan C; Chen Q; Tan T
Hua Xi Yi Ke Da Xue Xue Bao; 1994 Mar; 25(1):22-5. PubMed ID: 8070765
[TBL] [Abstract][Full Text] [Related]
25. Automatic preparation of radiopharmacokinetic data for in vivo estimation of receptor biochemistry.
Xu JC; Vera DR; Stadalnik RC
J Nucl Med; 1996 Nov; 37(11):1896-902. PubMed ID: 8917199
[TBL] [Abstract][Full Text] [Related]
26. Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis.
Ott P; Keiding S; Bass L
Hepatology; 1993 Dec; 18(6):1504-15. PubMed ID: 8244277
[TBL] [Abstract][Full Text] [Related]
27. Goodness-of-fit and local identifiability of a receptor-binding radiopharmacokinetic system.
Vera DR; Scheibe PO; Krohn KA; Trudeau WL; Stadalnik RC
IEEE Trans Biomed Eng; 1992 Apr; 39(4):356-67. PubMed ID: 1592401
[TBL] [Abstract][Full Text] [Related]
28. Use of an asialoglycoprotein receptor-targeted magnetic resonance contrast agent to study changes in receptor biology during liver regeneration and endotoxemia in rats.
Leveille-Webster CR; Rogers J; Arias IM
Hepatology; 1996 Jun; 23(6):1631-41. PubMed ID: 8675187
[TBL] [Abstract][Full Text] [Related]
29. Tc-99m galactosyl-neoglycoalbumin hepatic scintigraphy in fulminant hepatic failure.
Moragas M; Pavía J; Ginés A; Ros D; Solá M; Huguet M; Pons F; Setoain J
Clin Nucl Med; 1995 Apr; 20(4):329-33. PubMed ID: 7788990
[TBL] [Abstract][Full Text] [Related]
30. Liver function in acute viral hepatitis as determined by a hepatocyte-specific ligand: 99mTc-galactosyl-neoglycoalbumin.
Virgolini I; Müller C; Höbart J; Scheithauer W; Angelberger P; Bergmann H; O'Grady J; Sinzinger H
Hepatology; 1992 Apr; 15(4):593-8. PubMed ID: 1551636
[TBL] [Abstract][Full Text] [Related]
31. [Pharmacokinetic studies on 99mTc-NGA in human].
Guan C; Chen Q; Tan T
Hua Xi Yi Ke Da Xue Xue Bao; 1993 Sep; 24(3):268-70. PubMed ID: 8288194
[TBL] [Abstract][Full Text] [Related]
32. Radiopharmaceutical preparation of technetium-99m-labeled galactosyl neoglycoalbumin.
Vera DR; Stadalnik RC; Kudo M; Krohn KA
Methods Enzymol; 1994; 247():402-9. PubMed ID: 7898368
[No Abstract] [Full Text] [Related]
33. 99mTc-neoglycoalbumin (NGA)-binding to human hepatic binding protein (HBP) in vitro.
Virgolini I; Angelberger P; Müller C; O'Grady J; Sinzinger H
Br J Clin Pharmacol; 1990 Feb; 29(2):207-14. PubMed ID: 2306412
[TBL] [Abstract][Full Text] [Related]
34. Functional liver imaging with 99Tcm-galactosyl-neoglycoalbumin (NGA) in alcoholic liver cirrhosis and liver fibrosis.
Virgolini I; Müller C; Angelberger P; Höbart J; Bergmann H; Sinzinger H
Nucl Med Commun; 1991 Jun; 12(6):507-17. PubMed ID: 1866104
[TBL] [Abstract][Full Text] [Related]
35. Tc-99m human serum albumin: a suitable agent for plasma volume measurements in man.
Yang SS; Nickoloff EL; McIntyre PA; Maddrey WC; Mikesell HH; Scheffel U; Kasecamp W; MacAllister NP
J Nucl Med; 1978 Jul; 19(7):804-7. PubMed ID: 660283
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of hepatocellular function by way of receptor-mediated uptake of a technetium-99m-labeled asialoglycoprotein analog.
Pimstone NR; Stadalnik RC; Vera DR; Hutak DP; Trudeau WL
Hepatology; 1994 Oct; 20(4 Pt 1):917-23. PubMed ID: 7927233
[TBL] [Abstract][Full Text] [Related]
37. Measurement of functioning hepatocyte mass via [99mTc]galactosyl-neoglycoalbumin.
Kudo M; Vera DR; Stadalnik RC; Esquivel CO; Trudeau WL; Ikekubo K; Todo A
Dig Dis Sci; 1993 Dec; 38(12):2183-8. PubMed ID: 8261818
[TBL] [Abstract][Full Text] [Related]
38. [The preparation of hepatic receptor imaging agent 99mTc-DTPA-NGA].
Li Y; Guan C; Wang Q
Hua Xi Yi Ke Da Xue Xue Bao; 1996 Mar; 27(1):54-8. PubMed ID: 9208621
[TBL] [Abstract][Full Text] [Related]
39. [Estimation of hepatic functional reserve by asialoglycoprotein receptor-binding, radiolabeled synthetic ligand Tc-99m-galactosyl-neoglycoalbumin--preclinical and clinical studies].
Kudo M; Todo A; Ikekubo K; Hino M; Ito H; Yamaguchi H; Saiki Y; Yamamoto K; Yonekura Y; Torizuka K
Kaku Igaku; 1987 Nov; 24(11):1653-62. PubMed ID: 3446908
[No Abstract] [Full Text] [Related]
40. In vivo functional imaging using receptor-binding radiopharmaceuticals. Technetium 99m-galactosyl-neoglycoalbumin as a model.
Stadalnik RC; Kudo M; Eckelman WC; Vera DR
Invest Radiol; 1993 Jan; 28(1):64-70. PubMed ID: 8425855
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
